297
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

QSPR Analysis of Some Drug Candidates Investigated for COVID-19 via New Topological Coindices

ORCID Icon & ORCID Icon
Pages 1291-1308 | Received 28 Nov 2022, Accepted 09 Mar 2023, Published online: 27 Mar 2023
 

Abstract

The COVID-19 outbreak has appeared as a matchless global threat against all humanity. Even the most developed countries have been shocked by the adversities of the COVID-19 pandemic affecting social life, especially human health. All over the world, researchers still have been studying to develop new medicines the combat outbreak. A topological index can be thought of as the conversion of a chemical structure to a real number. Topological indices are often used to provide information about the physicochemical properties and biological properties of molecules. Topological coindices are the numeric values, obtained by the complement graph of a molecular structure, which is used in Quantitative Structure Property/Activity Relationship (QSPR/QSAR) studies to evaluate the physicochemical and biological properties of compounds. In this study, we construct some new topological coindices and define the concept of CoNM-polynomial. Owing to these polynomials we pass the difficulty of calculating the topological coindices. The computing process is done for the molecular graph structure of fixed analogs of Lopinavir, Favipiravir and Ritonavir. Afterward, obtained values are evaluated in QSPR modeling via linear and quadratic regression analysis to examine some physicochemical properties of the analog medicines such as enthalpy of vaporization (E), flash point (FP), molar refractivity (MR), polarizability (P), surface tension (T), molar volume (MV).

Acknowledgment

The authors received no financial support for the research of this article.

Author contributions

All authors have contributed equally to this work.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data used to support the findings of this study are included within the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.